Condition
Anorectal Cancer
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Not Yet Recruiting2
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06669572Phase 2Recruiting
Lenvatinib and Pembrolizumab to Treat Patients With Anal or Rectum Cancer That Has Gotten Worse After Initial Treatment
NCT07216456Not ApplicableNot Yet Recruiting
Vaginal Dilator Therapy After Pelvic Radiation
NCT05832385Not Yet RecruitingPrimary
Effects of Different Radiation Dosimetry for Anorectal Function of Patients With Pelvic Cancer
Showing all 3 trials